Acalabrutinib With Axi-Cel Reveals Promising Responses in R/R B-Cell Lymphoma.

Authors :: Flaherty, Courtney
Source :: Targeted Therapies in Oncology; Apr2024, Vol. 13 Issue 5, p39-40, 2p
Publication Year :: 2024

Subjects :: T cells
PROTEIN-tyrosine kinase inhibitors
IMMUNOTHERAPY
TREATMENT effectiveness
CELLULAR therapy
TUMOR markers
DRUG approval
DRUG efficacy
PROGRESSION-free survival
B cell lymphoma
OVERALL survival
DISEASE progression

Tools